FIELD: medicine. SUBSTANCE: proposed agent is 5-oxa-6-ketoprostaglandin E1 shows antiaggregation activity and can be used for bolus administration. It shows high stability at storage and low metabolism in organism. EFFECT: enhanced properties of agent. 6 tbl
Title | Year | Author | Number |
---|---|---|---|
ANTICOAGULATION DRUG | 1996 |
|
RU2146138C1 |
ANTIAGGREGANT | 2005 |
|
RU2353363C2 |
METHOD OF REDUCING AGGREGATION ACTIVITY OF PLATELETS in vitro | 2009 |
|
RU2410104C1 |
2-CYCLOALKYLAMINO-5-THIENYL-1,3,4-THIADIAZINES, HYDROBROMIDES, WITH ANTIAGGREGANT ACTIVITY | 2008 |
|
RU2379306C1 |
MEANS FOR INTENSIFYING ANTIAGGREGATION EFFECT OF ASPIRIN | 1991 |
|
RU2007170C1 |
5-(4'-HYDROXYPHENYL)-AND 5-(2',5'-DIHYDROXYPHENYL)-6 H-1,3,4-THIADIAZINE-2-AMINES, HYDROHALOGENIDES INHIBITING THROMBOCYTE AGGREGATION IN INTRAVENOUS INTRODUCTION | 2009 |
|
RU2458060C2 |
ANTIAGGREGATION AGENT | 1983 |
|
RU2045264C1 |
METHOD FOR PATIENT-SPECIFIC SELECTION OF ANTIPLATELET DRUGS FOR PATIENTS IN NEED THEREOF | 2012 |
|
RU2499261C1 |
CYCLOPHILIN A - AGENT ENHANCING THROMBOCYTE ADHESION PROPERTIES | 2010 |
|
RU2435607C1 |
METHOD FOR STUDYING ANTI-AGGREGATION ACTION OF PREPARATIONS BY DETERMINING BLOOD PLATELET AGGREGATION IN VITRO | 2000 |
|
RU2188419C2 |
Authors
Dates
1995-04-30—Published
1990-03-20—Filed